Latest Asx Disclosures News

Page 5 of 6
Botanix Pharmaceuticals has clarified that recent share price movements are linked to a rumored US executive order on drug pricing, confirming no undisclosed material information. The company reassures investors of compliance with ASX disclosure rules amid market speculation.
Ada Torres
Ada Torres
12 May 2025
Mayne Pharma Group has acknowledged a delayed filing of a director's interest notice due to administrative oversight and is taking steps to reinforce compliance with ASX disclosure rules.
Ada Torres
Ada Torres
12 May 2025
Tivan Limited has responded to ASX inquiries about a social media post by its executive chair concerning fluorite exploration, affirming compliance with disclosure rules and pending assay results.
Maxwell Dee
Maxwell Dee
7 May 2025
Yowie Group Ltd has responded to ASX queries detailing a significant revenue impact from reduced store facings and clarified complex loan arrangements with Keybridge Capital Limited amid ongoing solvency concerns.
Victor Sage
Victor Sage
2 May 2025
Dateline Resources has gained critical U.S. regulatory approval for its Colosseum Gold-REE Project, unlocking rare earth exploration rights and pursuing an OTCQB listing to engage American investors.
Maxwell Dee
Maxwell Dee
2 May 2025
Assetora Limited has dramatically reduced its net liabilities and strengthened its balance sheet through strategic capital raises and debt conversions, while unveiling a comprehensive rebrand and leadership expansion to drive its next growth phase.
Claire Turing
Claire Turing
1 May 2025
Bendigo and Adelaide Bank clarifies a modest 5.8% variance in half-year cash earnings against market forecasts, confirming no material surprise and compliance with ASX disclosure rules.
Claire Turing
Claire Turing
18 Feb 2025
Laramide Resources Ltd. has acknowledged a delayed filing of a director's interest notice due to internal illness, prompting an ASX inquiry and procedural upgrades to prevent future lapses.
Maxwell Dee
Maxwell Dee
14 Feb 2025
AUCyber Limited confirms control has passed to 5GN following a substantial holding disclosure, with the Board unanimously recommending shareholders accept 5GN's last and final offer closing on 17 February 2025.
Sophie Babbage
Sophie Babbage
4 Feb 2025
Epsilon Healthcare's December 2023 quarterly report reveals significant boardroom conflict and governance breaches, yet operational segments show promising growth.
Ada Torres
Ada Torres
31 Jan 2025
Gullewa Limited reports a robust cash balance of $9.087 million at the end of December 2024, supported by strong financing inflows despite ongoing exploration expenditures. The company’s quarterly cash flow highlights its strategic financial management as it advances key tenements in Western Australia.
Maxwell Dee
Maxwell Dee
29 Jan 2025
Lakes Blue Energy has responded to ASX concerns over delayed disclosure of director interest changes, attributing the issue to administrative oversights and reaffirming its commitment to compliance.
Maxwell Dee
Maxwell Dee
28 Jan 2025